Resources

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Achieving and Sustaining Remission while Reducing Organ Damage

Interviews with Three Key Opinion Leaders

European Medical Journal article

ASN 2019

Glucocorticoids for Remission Induction in Incident ANCA-Associated Vasculitis (AAV) Patients in Real-World Practice: High Exposure and Temporal Relationship to Adverse Events

Abstract Poster

Maintenance Treatment in ANCA-Associated Vasculitis (AAV): Definition, Clinical Outcomes, and Significant Burden of Disease in Real-World Clinical Practice

Abstract Poster

ERA-EDTA 2019

Adverse events and infections as major concerns with remission induction therapy of ANCA-associated vasculitis.

Poster

High burden of disease for AAV patients in Germany - a claims study.

Poster

Renal damage in ANCA-associated vasculitis in incident and relapsing patients.

Slide deck

EULAR 2019

Economic burden of ANCA-associated vasculitis in Germany - a claims data study.

Poster

Adverse events due to high-dose glucocorticoids - lessons from ANCA-associated vasculitis and other inflammatory diseases.

Poster

Severity and response to induction therapy in new and relapsing ANCA-associated vasculitis patients - real world practice data.

Poster

Vasculitis 2019 Workshop

Comorbidity, adverse events and infections are major concerns in real world management of ANCA-associated vasculitis.

Abstract Poster

Severity of ANCA-associated vasculitis and response to induction therapy in new and relapsing patients.

Abstract Poster

What is the ANCA-associated vasculitis community discussing online?

Abstract Poster

UK Renal week 2019

Variable response to induction therapy and significant burden of treatment adverse events over the first 12 months of remission induction treatment in ANCA-associated vasculitis patients.

Poster

BSR 2018

Management of ANCA-associated vasculitis in the UK: a complex pathway of patient referral, diagnosis, and treatment.

Poster

ACR 2018

Variable Response to Induction Therapy and Significant Burden of Treatment Adverse Events...

Abstract Poster

Patient Experience in ANCA-Associated Vasculitis Evolves over Time from from Diagnosis...

Abstract Poster

ASN 2018

Patient Experience in ANCA-Associated Vasculitis - Challenges from Diagnosis and Need for New Approaches.

Abstract Poster

Patients with Relapsing ANCA-Associated Vasculitis (AAV) Experience Unmet Needs around Remission Induction and Therapy Related Adverse Events.

Abstract Poster

Real World Experience in ANCA-Associated Vasculitis (AAV) – A Complex Pathway of Patient Referral, Diagnosis, and Management.

Abstract Poster

Response to Induction Therapy and Treatment Adverse Events in Incident ANCA-Associated Vasculitis (AAV) Patients.

Abstract Poster

Adverse Events Due to Glucocorticoids in ANCA-Associated Vasculitis Are Frequent but Reporting Should Improve.

Abstract Poster

Introduction to AAV

AAV is a rare, severe small vessel vasculitis that affects multiple organs and has a high acute mortality risk

Disease mechanism

The interaction between the activated alternative complement pathway, neutrophils and C5a is at the heart of vasculitic damage in AAV

Current therapies

Treatment has improved but treatment-related complications remain common

Patient experience

AAV is an emotional journey from the patient's perspective

Investigate AAV

Take the interactive challenge to assess your understanding of AAV. Fully interactive version available on desktop only